pharmacy Archives

The Authors’ Own Words: Integration of a Clinical Pharmacy Specialist into a Substance Use Disorder Training drug addiction counselors to deliver a brief psychosocial psychoeducational intervention for chronic pain among patients in opioid agonist treatment: A pilot investigation.

Jan 7, 2020 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Integration of a Clinical Pharmacy Specialist into a Substance Use Disorder Training drug addiction counselors to deliver a brief psychosocial psychoeducational intervention for chronic pain among patients in opioid agonist treatment: A pilot investigation.

Jenna L. Butner MD; Curtis Bone MD; Caridad C. Ponce Martinez MD; Grace Kwon MD; Mark Beitel PhD; Lynn M. Madden PhD; Madeline H. Bono; Anthony Eller BS; & Declan T. Barry PhD

Substance Abuse Vol. 39, Iss. 2, 2018

“Initiatives to reduce providers’ perceived inability, reported discomfort, and lack of interest in managing chronic pain have centered on enhancing curricula at medical and professional schools. This approach has met with mixed success; it appears that training providers on a biomedical model of pain management emphasizing pathophysiology, pharmacotherapy, and surgical interventions does not automatically enhance perceived ability to manage chronic pain. Findings from this pilot study suggest that it is both feasible and acceptable to train front-line opioid agonist treatment drug counselors with an inexpensive, brief, onsite psychoeducational intervention for assessing and addressing chronic pain; on average attendees continued to perceive a beneficial effect on their clinical work with patients six months later. These findings underscore the importance of conducting further research on training providers, including those in opioid agonist treatment settings, on the biopsychosocial model of chronic pain, and targeting strategies that might enhance their clinical management of patients with chronic pain.”

The Authors’ Own Words: Integration of a Clinical Pharmacy Specialist into a Substance Use Disorder Intensive Outpatient Treatment Program to Improve Prescribing Rates of Alcohol Use Disorder Pharmacotherapy

Jan 6, 2020 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Integration of a Clinical Pharmacy Specialist into a Substance Use Disorder Intensive Outpatient Treatment Program to Improve Prescribing Rates of Alcohol Use Disorder Pharmacotherapy

Erica Dimitropoulos PharmD, Stephanie Bertucci LICSW; & Kara Wong PharmD, BCPP

Substance Abuse Vol. 39, Iss. 2, 2018

“The pharmacist’s role in the management of substance use disorders is not currently well defined. In an effort to explore this further, our study employed a bridge service that utilized pharmacists to improve access to evidence-based alcohol use disorder pharmacotherapy. Using this model, we were able to optimize treatment by offering medications to supplement psychotherapy for patients enrolled in an intensive outpatient program. Our intervention serves as an example for other facilities looking for novel ways to integrate pharmacists into substance use disorder clinics.”

The Authors’ Own Words: Telephone-Based Opioid Overdose Education and Naloxone Distribution (OEND) Pharmacy Consult Clinic

Dec 31, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Telephone-Based Opioid Overdose Education and Naloxone Distribution (OEND) Pharmacy Consult Clinic

Eric M. Szydlowski PharmD & Stephen S. Caruana PharmD

Substance Abuse Vol. 39, Iss. 2, 2018

“The article provides outline and practical information on a large scale pharmacy-based naloxone education and distribution initiative. This process could be implemented at other VA facilities and offers insights that could be adapted to improve community access to naloxone through pharmacy engagement elsewhere.”